Crinetics Pharmaceuticals
Trade Crinetics Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CRNX
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.
CRNX Key Statistics
Stock Snapshot
The current Crinetics Pharmaceuticals(CRNX) stock price is $39.26, with a market capitalization of 4.11B. The stock trades at a price-to-earnings (P/E) ratio of -7.99.
As of 2026-03-05, Crinetics Pharmaceuticals(CRNX) stock has fluctuated between $38.59 and $39.75. The current price stands at $39.26, placing the stock +1.7% above today's low and -1.2% off the high.
Crinetics Pharmaceuticals(CRNX) shares are trading with a volume of 71.99K, against a daily average of 948.46K.
During the past year, Crinetics Pharmaceuticals(CRNX) stock moved between $24.10 at its lowest and $57.99 at its peak.
During the past year, Crinetics Pharmaceuticals(CRNX) stock moved between $24.10 at its lowest and $57.99 at its peak.
Analyst ratings
100%
of 15 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.